1. Home
  2. AXIA vs RMD Comparison

AXIA vs RMD Comparison

Compare AXIA & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AXIA

AXIA Energia American

N/A

Current Price

$12.60

Market Cap

29.0B

Sector

Utilities

ML Signal

N/A

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$207.28

Market Cap

32.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXIA
RMD
Founded
1962
1989
Country
Brazil
United States
Employees
7710
10600
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.0B
32.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AXIA
RMD
Price
$12.60
$207.28
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$292.56
AVG Volume (30 Days)
2.6M
1.1M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
6.68%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.92
$10.60
Revenue Next Year
$7.32
$7.41
P/E Ratio
N/A
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$8.78
$198.64
52 Week High
$13.54
$293.81

Technical Indicators

Market Signals
Indicator
AXIA
RMD
Relative Strength Index (RSI) 55.89 31.99
Support Level $10.52 N/A
Resistance Level $12.66 $260.21
Average True Range (ATR) 0.29 5.43
MACD -0.08 -1.16
Stochastic Oscillator 43.07 27.19

Price Performance

Historical Comparison
AXIA
RMD

About AXIA AXIA Energia American

Axia Energia is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: